title: Prostate cancer: the right treatment for the right patient. Amsterdam, 17-18 January 2001.
authors.affiliation: Academic Medical Center, Amsterdam, The Netherlands. T.M.deReyke@AMC.UVA.NL
authors.forename: T M
authors.initials: TM
authors.lastname: De Reijke
authors.forename: H P
authors.initials: HP
authors.lastname: Beerlage
authors.forename: A J M
authors.initials: AJ
authors.lastname: Hendrikx
authors.forename: J J M C H
authors.initials: JJ
authors.lastname: De La Rosette
authors.forename: C A
authors.initials: CA
authors.lastname: McKillop
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077868:Atrasentan; D001918:Brachytherapy / Q000379:methods; D003131:Combined Modality Therapy; D017679:Cryotherapy / Q000379:methods; D006801:Humans; D010535:Laparoscopy / Q000379:methods; D008297:Male; D009367:Neoplasm Staging; D010347:Patient Care Planning; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery*; D011759:Pyrrolidines / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011759:Pyrrolidines; D017430:Prostate-Specific Antigen; D000077868:Atrasentan